AbbVie

In a city with high-profile industries like higher education and health care, the biggest businesses tend to be tax-exempt.

Five Central Massachusetts life sciences companies are splitting $5 million in tax incentives to create 245 jobs in the region.

The project will involve other site improvements, including the construction of outdoor patios, landscape improvements. A portion of Research Drive will be relocated to segregate pedestrian and truck traffic.

Chicago-based biotech giant AbbVie, which has a large bioresearch facility in Worcester, will acquire Waltham’s ImmunoGen and its flagship ovarian cancer treatment drug in an more than $10-billion transaction.

Large for-profit life sciences companies have called Central Mass. their home for decades. Now, they play an important role in bringing talent, investment, and research to the region.

Researchers across Central Mass. are leading development of cutting-edge ideas and therapies to provide the next generation of solutions to present and future problems.

AbbVie, a Chicago-based biotech company with a bioresearch facility in Worcester, will partner with Belgian eye-care researcher iSTAR Medical to develop and commercialize a device to treat glaucoma.

On Wednesday, June 29, AbbVie built Forest Grove Middle School’s STEM lab, but their efforts stretch farther than just this single, advantageous event.

More than 150 employees from the Worcester facility of Illinois pharmaceutical company AbbVie are building a STEM lab for Forest-Grove Middle School in Worcester.

Worcester's top taxpayers included a couple large players in the downtown block near Worcester Common, as well as several utility companies.